---
title: Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit
nct_id: NCT01299025
overall_status: COMPLETED
phase: NA
sponsor: Örebro County Council
study_type: INTERVENTIONAL
primary_condition: Multiple Sclerosis
countries: Sweden
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01299025.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01299025"
ct_last_update_post_date: 2015-04-24
last_seen_at: "2026-05-12T06:01:37.185Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit

**NCT ID:** [NCT01299025](https://clinicaltrials.gov/study/NCT01299025)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 84
- **Lead Sponsor:** Örebro County Council
- **Collaborators:** Uppsala-Örebro Regional Research Council, Norrbacka-Eugenia Foundation
- **Conditions:** Multiple Sclerosis
- **Start Date:** 2010-09
- **Completion Date:** 2011-06
- **CT.gov Last Update:** 2015-04-24

## Brief Summary

The aim is to evaluate balance training using Nintendo Wii Fit. The hypothesis is that a period of training will increase balance capacity och self-efficacy.

People with diagnosed multiple sclerosis are invited to participate. Estimation of study power gave that 29 people in each group was necessary to detect a difference in the primary outcome measure, Timed Up and Go test.

Other measures used are the Four square step test, Dynamic Gait Index, Timed stands test, 25 foot walking test, 12-item Walking scale and the ABC scale.

Participants were randomised to either training or control. The training consisted of 6 weeks training with Nintendo Wii Fit 30 minutes 2 times a week.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Diagnosed multiple sclerosis
* Subjective experience of affected balance and walking
* Being able to walk 100 meters with assistance

Exclusion Criteria:

* Cognitive or language deficits that prevents using the self-rating scales
* Visual deficits that prevents training with television games
* Weight above 149 kg
```

## Arms

- **Control** (NO_INTERVENTION) — Participants allocated as controls receive no treatment. They may be physically active as usual.
- **Training with Nintendo Wii Fit** (EXPERIMENTAL) — Training 6 weeks with Nintendo Wii Fit, 30 minutes 2 times per week

## Interventions

- **Training using Nintendo Wii Fit** (OTHER) — Training 2 times per week, 30 minutes, for 6 weeks.

## Primary Outcomes

- **Change in Timed Up and Go Test From Day 1 to Day 42** _(time frame: Measured at day 1 (before the training period) and at day 42 (after the training period))_ — Change in seconds on the Timed Up and Go test (TUG). In the TUG test time is taken from rising from a chair, walking 3 meters, turning,walking back and sitting down.

## Secondary Outcomes

- **Change in Score on the Dynamic Gait Index From Day 1 to Day 42** _(time frame: Measured at day 1 (before training) and day 42 (after training))_
- **Change in the Activities-specific Balance Confidence (ABC) Scalefrom Day 1 to Day 42** _(time frame: Measured at day 1 (before training) and day 42 (after training))_
- **Change in the 12 Item Walking Scale From Day 1 to Day 42** _(time frame: Measured at day 1 and day 42, before and after the training)_

## Locations (4)

- Mälarsjukhuset, Eskilstuna, Sweden
- Karlstad hospital, Karlstad, Sweden
- Family Medicine Research centre, Örebro, Sweden
- Västerås hospital, Västerås, Sweden

## Recent Field Changes (last 30 days)

- `design.enrollmentCount` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.mälarsjukhuset|eskilstuna||sweden` — added _(2026-05-12)_
- `locations.karlstad hospital|karlstad||sweden` — added _(2026-05-12)_
- `locations.family medicine research centre|örebro||sweden` — added _(2026-05-12)_
- `locations.västerås hospital|västerås||sweden` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01299025.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01299025*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*